⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVCR News
NovoCure Limited Ordinary Shares
Single Injection of JointStem Demonstrates Sustained Clinical Benefits Over Five Years
accessnewswire.com
NVCR
Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight
prnewswire.com
BNTX
NVCR
ONCO
AZN
MRK
MRUS
Novocure Appoints Company President Frank Leonard as Chief Executive Officer
businesswire.com
NVCR
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
businesswire.com
NVCR
Novocure to Participate in 2025 Jefferies Global Healthcare Conference
businesswire.com
NVCR
Novocure Reports Third Quarter 2025 Financial Results
businesswire.com
NVCR
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress
businesswire.com
NVCR
Novocure to Report Third Quarter 2025 Financial Results
businesswire.com
NVCR
Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting
businesswire.com
NVCR